Advisory group urges stronger labels on antidepressants

A federal advisory group voted to include "black box" warnings about the suicide risk in younger people on the sheets doctors review when prescribing drugs for all the antidepressants on the market. The warnings, the "strongest emphasis on warning information" the industry can use, also would be supplemented by a patient guide for the drugs written in plain language.

View Full Article in:

NYTimes.com · Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park